Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma
Conditions:   Hemangioma;   Kaposiform Hemangioendothelioma Interventions:   Drug: Sirolimus(0.8mg/m2);   Drug: Sirolimus(0.7mg/m2) Sponsor:   Children's Hospital of Fudan University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 4, 2019 Category: Research Source Type: clinical trials

Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma
Condition:   Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma Intervention:   Drug: Tacrolimus ointment Sponsor:   West China Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2019 Category: Research Source Type: clinical trials

Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients
Conditions:   Soft Tissue Sarcoma Adult;   Undifferentiated Pleomorphic Sarcoma;   Epithelioid Sarcoma;   Solitary Fibrous Tumors;   Hemangioendothelioma;   Desmoplastic Round Cell Tumor;   Synovial Sarcoma Intervention:   Drug: Trabectedin Sponsor:   Institut Bergonié Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 4, 2019 Category: Research Source Type: clinical trials

Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group
Conditions:   Soft Tissue Sarcoma;   Clear Cell Sarcoma;   Epithelioid Sarcoma;   Perivascular Epithelioid Cell Neoplasms;   Desmoplastic Small Round Cell Tumor;   Solitary Fibrous Tumors;   Alveolar Soft Part Sarcoma;   Epithelioid Hemangioendothelioma;   Low Grade Fibromyxoid Sa rcoma;   Sclerosing Epithelioid Fibrosarcoma Intervention:   Other: Patient with Soft Tissue Sarcoma Sponsor:   Institut Claudius Regaud N...
Source: ClinicalTrials.gov - May 30, 2019 Category: Research Source Type: clinical trials

Diagnostic Accuracy of PIVKA-II Combining With Alpha-Fetoprotein in Hepatic Tumor
Conditions:   Hepatoblastoma;   Hepatic Hemangioendothelioma Intervention:   Diagnostic Test: PIVKA-II Sponsors:   Shanghai Children's Medical Center;   Beijing Children's Hospital;   Chidren's Hospital of Fudan University;   Chongqing Children's Hospital, Chongqing Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2018 Category: Research Source Type: clinical trials